INTERREG France-Wallonie-Vlaanderen – PATHACOV – Early diagnosis of human diseases through analysis of VOC in exhaled breath

Goal: 

Analyse and characterise specific markers VOC (volatile organic compounds) of the lung cancer to improve early diagnosis of such a cancer

Activities carried out by Eurasanté:

  • Responsible fot the communication part of the project
  • Design of main communication supports: Poster, roll-up banner, newsletters, etc.
  • Organisation of launching and closure events, jointly with press conferences
  • Monitoring of scientific progress and preliminary intellectual property (IP) study
  • Preparation of a health promotion plan and raising awareness on lung cancer: mapping of associations, institutions and local authorities in the programme area

Duration: 48 months

Official start: 01.10.2018

Budget: €4 638 521

Head of project: Lille University Hospital – FR

Partners:

  •  Reims University Hospital (FR)
  • KU Leuven (BE)
  • École Nationale Supérieure Mines Télécom Lille Douai (FR)
  • Materia Nova (BE)
  • University of Liège, campus Arlon (BE)
  • University of Reims (FR)
  • University of Mons (BE)
  • University of Lille (FR)
  • Amiens University Hospital (FR)
  • Eurasanté (FR)

Download the pathacov project flyer